Bulk purchasing and value-based pricing of pharmaceuticals

Wednesday, May 2nd, 2012
2:00pm ET
(Broadcast in English only)

Watch the Video



Bulk-purchasing is an effective way to reduce spending on pharmaceuticals across Canada. HTA is a tool that helps determine the value of the drugs and price them accordingly. Working with both of these concepts could yield numerous benefits to our system. Can these two approaches be linked to reduce spending and increase accessibility to important treatments?


Join the discussion!


Guest Speakers:


Don Husereau image Don Husereau, Adjunct Professor at University of Ottawa


Don Husereau is adjunct professor at University of Ottawa, Faculty of Medicine and editorial advisor for Value in Health journal. He was formerly senior advisor for the Canadian Agency for Drugs and Technologies in Health (CADTH). While there, he developed and led an environmental scanning program, a rapid review service and their process for prioritizing technology assessment. He also led the completion of the CADTH Health Technology Assessment Guidelines for the Economic Evaluation of Health Technologies and chaired Canada’s Health Technology Analysis Exchange. He received his BSc in pharmacy (1993) and MSc (2000) from the University of Alberta.

Eric Lun imageEric Lun, Executive Director, Drug Intelligence, Pharmaceutical Services Division, BC Ministry of Health Services


In his current role within Pharmaceutical Services Division, Ministry of Health Services, Eric leads the Drug Intelligence branch.  The branch consists of several operating units including Formulary Management, Special Authority, Clinical Decision Support, and the Alzheimer’s Drug Therapy Initiative.  Formulary Management is responsible for the PharmaCare drug review process and benefit listing decisions while the Special Authority program is responsible for adjudicating requests for limited coverage drugs. Prior to joining PSD, Eric worked with the Vancouver Coastal Health Authority as Regional Coordinator, Medication Use Management, responsible for managing the Health Authority’s drug formulary. Eric has also worked as a financial research analyst for the biotech and healthcare sector (TD Securities), as a clinical pharmacist (Vancouver General Hospital), a Drug Use Evaluation pharmacist (University of Alberta Hospital), and a pharmacy lecturer (University of Technology, Jamaica).




Stephen Samis imageStephen Samis, Vice-President, Programs, CHSRF 


Stephen has more than 15 years experience in research, policy development, knowledge exchange, partnership development and advocacy in the health sector. Prior to CHSRF he was director of Health Policy at the Heart and Stroke Foundation of Canada from 2004 to 2010 and manager of Research and Analysis at the Canadian Institute for Health Information from 2000 to 2004. Before moving to Ottawa in 2000, Stephen was a health research and policy consultant in British Columbia, where he worked for the BC Ministry of Health, Health Canada, the BC Workers Compensation Board and others.


Stephen has a strong interest in health research and policy, population health and evidence-informed policy development to improve Canada's health systems and ultimately the health of Canadians. He holds a Master’s degree in Sociology from Simon Fraser University in British Columbia.